|
CAS
|
152-11-4
|
|
中文名称
|
盐酸维拉帕米
|
|
英文名称
|
Verapamil Hydrochloride
|
|
别名
|
维拉帕米盐酸盐; 苯噻嗪
|
|
纯度
|
HPLC≥98%
|
|
分子式
|
C27H38N2O4·HCl
|
|
分子量
|
491.06
|
|
外观（性状）
|
White to off-white Solid
|
|
储存条件
|
Powder : 2-8℃, 2 years; In solvent(母液): -20℃, 1 month; -80℃, 6 months
|
|
溶解性
|
Soluble in DMSO ≥50mg/mL
|
|
MDL
|
MFCD00069355
|
|
EC
|
EINECS 205-800-5
|
|
InChIKey
|
DOQPXTMNIUCOSY-UHFFFAOYSA-N
|
|
InChI
|
InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H
|
|
PubChem CID
|
62969
|
|
SMILES
|
[H]Cl.COC1=CC=C(C(C#N)(C(C)C)CCCN(CCC2=CC=C(OC)C(OC)=C2)C)C=C1OC
|
|
描述
|
Verapamil Hydrochloride为一种钙离子拮抗剂。(Verapamil Hydrochloride is considered as a calcium antagonist.)
|
|
靶点
|
Calcium Channel
|
|
通路
|
Membrane Transporter&Ion Channel;Neuronal Signaling
|
|
生物活性
|
Verapamil hydrochloride 是钙离子通道 (calcium channel) 拮抗剂。[1-3]
|
